title: Population and economic impact of the 2013 ACC/AHA guidelines compared with European guidelines to prevent cardiovascular disease.
authors.affiliation: Department of Medicine, Internal Medicine, CHUV and Faculty of Biology and Medicine, Bâtiment des Instituts, Etude CoLaus, 19, rue du Bugnon, Lausanne 1005, Switzerland.
authors.forename: Julien
authors.initials: J
authors.lastname: Vaucher
authors.forename: Pedro
authors.initials: P
authors.lastname: Marques-Vidal
authors.forename: Martin
authors.initials: M
authors.lastname: Preisig
authors.forename: Gérard
authors.initials: G
authors.lastname: Waeber
authors.forename: Peter
authors.initials: P
authors.lastname: Vollenweider
mesh_terms: D000368:Aged; D000572:American Heart Association; D000069059:Atorvastatin; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005060:Europe; D005260:Female; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011758:Pyrroles / Q000627:therapeutic use; D012955:Societies, Medical; D014481:United States
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin